Injective Price Surges 20%, Pineapple Financial's $2M INJ Acquisition and Buyback Signals Bullish Narrative.

The Injective price surged 20% intraday, driven by capital from Pineapple Financial's $2 million acquisition of INJ tokens, which brings its treasury holdings to 7.02 million tokens. The firm's conviction in INJ remains unchanged. Supply dynamics are tightening, with exchange balances dropping and supply outside exchanges climbing. The Injective price has broken out of a 24-month falling wedge pattern, with some targeting $8.00 in the short term and $20 longer term.